1 / 18

GENES and TOBACCO USE

GENES and TOBACCO USE. CAN GENES PREDICT WHO WILL…. develop heart disease? develop lung cancer? become a smoker? be able to quit?. FACTORS CONTRIBUTING to TOBACCO USE. Environment Tobacco advertising Conditioned stimuli Social interactions. Physiology Genetic predisposition

atara
Download Presentation

GENES and TOBACCO USE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GENES and TOBACCO USE

  2. CAN GENES PREDICT WHO WILL… • develop heart disease? • develop lung cancer? • become a smoker? • be able to quit?

  3. FACTORS CONTRIBUTING toTOBACCO USE Environment • Tobacco advertising • Conditioned stimuli • Social interactions Physiology • Genetic predisposition • Coexisting medical conditions Tobacco Use Pharmacology • Alleviation of withdrawal symptoms • Weight control • Pleasure

  4. AVAILABLE EVIDENCE • Adoption studies • Twin studies • Twins reared apart studies • Linkage (family) studies

  5. ADOPTION STUDIES Adoption studies compare the similarities between • Children who have been adopted and their biological parents versus children who have been adopted and their adoptive parents - OR - • Adoptive sibling pairs versus biological sibling pairs

  6. ADOPTION STUDIES (cont’d) Correlations between relatives for average reported cigarette consumption Biological Nonbiological Eysenck HJ, 1980.

  7. TWIN STUDIES Twin studies compare the similarities between • Identical (monozygotic) twins and fraternal (dizygotic) twins Concordant or discordant? Higher concordance of tobacco use for identical than for fraternal twins Estimated heritability for smoking = 0.53

  8. TWINS REARED APART STUDIES • Combine aspects of adoption and twin studies • Separate the effects of genetics from the effects of environment • Have found that 60% of the variance in regular smoking in men and women born after 1940 is attributable to genetic factors (Kendler et al., 2000)

  9. LINKAGE STUDIES • Use human genome mapping to enable researchers to identify genes associated with traits or disorders • Examine family pedigrees to determine modes of inheritance of disorders • Are more difficult when multiple genes have a role

  10. LINKAGE STUDIES (cont’d) Linkage studies of smoking • Identify families with affected individuals (i.e., tobacco users) • Genotype two or more affected siblings and biological parents • Conduct linkage analysis to determine whether affected siblings are likely to share the same gene as the parents

  11. “CANDIDATE” GENES • Candidate genes are genes hypothesized to contribute to the susceptibility for a trait or disorder. • Two current lines of research in the area of candidate genes for smoking: • Genes affecting nicotine pharmacodynamics • Genes affecting nicotine pharmacokinetics

  12. P h a r m a c o l o g y Pharmacodynamics Pharmacokinetics • DOPAMINE • Synthesis • Tyrosine hydroxylase • Receptor activation • DRD1, DRD2, DRD3, DRD4, DRD5 • Reuptake • Dopamine transporter (SLC6A3) • Metabolism • Catechol-O -methyltransferase • MAO A, MAO B • Dopamine ß-hydroxylase • SEROTONIN • Synthesis • Tryptophan hydroxylase (TPH) • Reuptake • Serotonin transporter (5-HTT) • Nicotine Metabolism • CYP2A6 enzyme • CYP2D6 enzyme

  13. Genetic Effects on the Dopamine Reward Pathway

  14. GENETIC EFFECTS on NICOTINE METABOLISM 4.4% 9.8% Nicotine-1'- N-oxide 0.4% Nicotine Nornicotine Nicotine glucuronide Nicotine 4.2% Trans-3'- hydroxycotinine ~80% 33.6% Trans-3'- hydroxycotinine Cotinine Cotinine 13.0% Trans-3'- hydroxycotinine glucuronide Cotinine glucuronide 7.4% Norcotinine 12.6% Cotinine- N-oxide 2.0% Reprinted with permission, Benowitz et al. (1994). 2.4%

  15. GENETIC EFFECTS on NICOTINE METABOLISM (cont’d) Nicotine CYP2A6 Aldehyde oxidase Cotinine

  16. GENES AND TOBACCO USE:SOCIETAL AND POLICY IMPLICATIONS If genetic tests become available, should society encourage genetic testing for tobacco dependence? • Single gene or multiple gene? • Prevalence of the gene(s) in the population? • Is there an effective intervention to prevent smoking in those who are susceptible? • Impact of positive tests, and negative tests?

  17. GENES AND TOBACCO USE:SOCIETAL AND POLICY IMPLICATIONS (cont’d) Improved treatment for tobacco dependence? • Perhaps the most promising benefit of genetic research on smoking • Improved understanding of tobacco dependence might result in development of more effective medications • Pharmacotherapy treatment matching

  18. GENES and TOBACCO USE: SUMMARY • Research in the area of genetics and smoking is in its infancy; however, there appears to be a genetic component to tobacco use. • Tobacco use is a complex behavior, with many determinants. • More research is needed. • Genetic research and testing must proceed with caution because the societal stakes are high.

More Related